Dr. Najarian, as the director of the Biomedical and Clinical Informatics Lab at the University of Michigan, is a distinguished researcher in the field of computational medicine, with a primary focus on leveraging artificial intelligence (AI) and machine learning (ML) for medical applications through clinical decision support systems and drug discovery and assessment. Resulting AI-based technologies for clinical decision support systems, which have been funded by agencies such as NSF, NIH, and DoD, feature advanced signal/image processing and ML techniques. In addition, he has collaborated with industry giants including J&J, BMS, and Toyota aimed at developing AI-based medical decision support systems for cardiovascular and gastrointestinal diseases. The success of these endeavors is evident in the licensing of these technologies to private companies, highlighting the real-world impact in advancing healthcare through computational medicine. Dr. Najarian is an Associate Director of the Michigan Institute for Data Science (MIDAS), focusing specifically on the integration of AI in healthcare and an Associate Director of the Weil Institute where he directs efforts toward AI applications in critical care. These roles signify Dr. Najarian’s commitment to driving innovation and improving patient outcomes through the implementation of cutting-edge AI technologies. Furthermore, as the Director of the Center for Data-Driven Drug Development and Treatment Assessment (DATA), an NSF IUCRC, Dr. Najarian coordinates all activities in this national center towards advancing the frontier of AI in drug development and contributes significantly to research in this field.